Private equity firm swoops for global labelling specialist
Tamworth-based labelling and artwork management specialist Kallik is set for rapid expansion after being acquired by FPE Capital, a growth equity investor in specialist technology companies.
Kallik is global provider of labelling and artwork management solutions for highly regulated industries, such as the pharmaceutical, medical devices, cosmetics and chemicals industries, and its clients include Cardinal Health, Integra and Exxon Mobil.
FPE says it will combine the existing successful Kallik team with a seasoned executive team to accelerate growth.
David Bennett, former CEO at FPE Capital investee company Inforsense and former president, sales and marketing at Zinc Ahead, a high-growth compliance SaaS provider to the pharmaceutical industry, will join the business as CRO.
John Hawkins, an experienced software executive and former chair of FPE investment Kallidus, has also joined the board as non-executive chairman.
David Barbour, managing partner at FPE, said: “FPE are delighted to have completed the buyout of Kallik, a visionary business addressing regulated industries on a global scale. Our expertise is focussed on delivering accelerated growth in companies operating in large markets that are experiencing change.
“We recognise those characteristics here and are excited to be partnering with Ash, David and John to take advantage of that shift.”
Ashley Goldie, managing director of Kallik, added: “I’m delighted to announce this news today which heralds exciting times ahead for both our customers and our employees. FPE Capital’s investment demonstrates complete confidence in both our products and our forward revenue projections.
“The acquisition will accelerate the ambitious growth of our business across all areas, including our technologies, infrastructure and people and provides access to a team of specialists with a proven track record in delivering outstanding growth and expansion into new markets and territories.”
